"From the wound dressing trial there doesn`t seem to be any foam offering by KCI that can`t be replaced by Polynovo..." But it looks like KCI are now looking in an entirely different direction.
KCI throwing $485 million at Systagenix doesn't bode well for a deal with Polynovo. It looks like KCI have hitched their wagon to another horse. I think KCI would rather take over than license.
What I fail to understand it the infatuation with collagen scaffolds.
- Forums
- ASX - By Stock
- CZD
- it all about the scaffold !!
it all about the scaffold !!, page-8
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)